Perhaps the most dramatic move of late on the OTC has come in shares of Vystar Corp. Common Stock (OTCMKTS:VYST). The stock has boomed higher on the back of new products, ripping over 3500% in the past month on a massive surge in relative volume of trade.
Helping to spark the recent extension of that movement, the company just announced that new and improved RxAir UV Light Air Purifiers are now available to combat cold, flu and other airborne germs that are more pervasive during the winter. According to the release, “Vystar acquired RxAir approximately nine months ago and immediately began upgrading the air purifiers to improve performance and longevity. The first upgraded RxAir units are now available for purchase via RxAir.com, Rotmans.com, Rotmans Furniture & Carpet in Worcester, Mass., and RxAir medical distributors.”
Vystar Corp. Common Stock (OTCMKTS:VYST) promulgates itself as a company that manufactures and sells Vytex natural rubber latex (NRL) products to the manufacturers of rubber and rubber end products in the United States.
The company owns a technology to produce Vytex NRL, which reduces antigenic protein in natural rubber latex products to virtually undetectable levels in liquid NRL and finished latex products. Its NRL or latex substitutes are used in a range of products, including balloons, textiles, footwear and clothing, adhesives, foams, furniture, carpets, paints, coatings, protective equipment, and sporting equipment, as well as health care products, such as condoms, surgical and exam gloves.
The company was founded in 2000 and is based in Worcester, Massachusetts.
Vytex is currently used in multiple mattress lines, including Natura™, and Gold Bond®; Jeffco manufactured components for toppers and mattresses, which are sold to multiple manufacturers; and private label toppers, pillows and mattresses sold online via sites such as Amazon and Bed Bath & Beyond. Vytex is also used in industrial adhesives, apparel padding and threads, shoes, sports equipment and electrical gloves and Vytex 3D printed fabrics available through partners like Tami Care. Liquid Vytex can be ordered wholesale through Halcyon Agri’s RCMA and CentroTrade. Vystar continues development of new Vytex formulations and is seeking additional manufacturing and development partners for numerous products.
According to company materials, “Based in Worcester, Mass., Vystar Corp. (OTC Pink: VYST) is the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products, and the owner of RxAir UV light air purification products. Vytex NRL is a 100% renewable resource, environmentally safe, “green” and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows.”
Find out when $VYST reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
As noted above, VYST just announced that new and improved RxAir UV Light Air Purifiers are now available to combat cold, flu and other airborne germs that are more pervasive during the winter.
Recent action has seen nearly 3900% piled on for shareholders of the listing during the trailing month. In addition, the name has benefitted from a jump in recent trading volume to the tune of approaching 670% above its longer-run average levels.
“Flu vaccines only protect you from a few flu strains and none of them protect you from the common cold and many other illnesses,” stated Bryan Stone, MD, Internal Medicine and Nephrology, Chief of Medicine for Desert Regional Medical Center. “Using UV light to kill airborne germs has been proven as an effective hospital infection control technology for years. The new RxAir now provides an even more effective way to bring this technology into your home or office to reduce your exposure to these pathogens to help avoid infection.”
Currently trading at a market capitalization of $13.65M, VYST has a store ($191K) of cash on the books, which is balanced by about $1.9M in total current liabilities. VYST is pulling in trailing 12-month revenues of $256K. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 3373%. You can bet we will update this one again as new information comes into view. Sign-up for continuing coverage on shares of $VYST stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in $VYST, either long or short, and we have not been compensated for this article.